6-chloro-3-ethyl[1,2,4]triazolo[4,3-b]pyridazine, 95.0%, 1g

6-Bromo-2-fluoropyridin-3-ol, 95.0%, 250mg

3-ETHYL-3-HYDROXY-AZETIDINE HCL, 97.0%, 100mg

Methyl 1-Bromocyclopentanecarboxylate, 95.0%, 100mg

GC capillary column ROTI®Cap-624, 25 m, 0.25 mm, 1.40 µm, 1 Piece(s)

2,2',2''-(2,4,6-Trifluorobenzene-1,3,5-triyl)tris(4,4,5,5-tetramethyl-1,3,2-dioxaborolane), 98%, 1g

5-Bromo-2,4-difluorophenol, 95.0%, 5g

2-Fluoro-5-(trifluoromethoxy)benzoic acid, 95.0%, 10g

tert-Butyl 4-(4-nitro-1H-pyrazol-1-yl)piperidine-1-carboxylate, 97%, 25g

(Z)-2-(2-((tert-Butoxycarbonyl)amino)thiazol-4-yl)pent-2-enoic acid, 95.0%, 50g

(2R,3R,4S,5R,6R)-2-(hydroxymethyl)-6-(3-nitrophenoxy)tetrahydro-2H-pyran-3,4,5-triol, 98%, 250mg

1-(4-BROMOPHENYL)-2-METHYLPROPAN-1-AMINE HCL, 95%, 100mg

4-Methoxy-2-methyl-indole, 97.0%, 1g